Europe — EMA
Nefrosol Kálium B. Braun Avitum
GNH USA supplies Nefrosol Kálium B. Braun Avitum (electrolyte solution), a intravenous electrolyte replacement for electrolyte depletion, metabolic acidosis
Request sourcing
What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?
Sodium Hydrogen Carbonate, the active ingredient in Nefrosol Kálium B. Braun Avitum, is an electrolyte solution presented as an intravenous solution for intravenous use. It treats electrolyte depletion, metabolic acidosis, and fluid replacement in hospitalized patients.
GNH USA supplies Nefrosol Kálium B. Braun Avitum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc used for?
Nefrosol Kálium is an intravenous electrolyte solution used to correct disturbances in the electrolyte and acid‑base balance. - Electrolyte depletion: restores normal plasma concentrations of sodium, potassium, magnesium, calcium, and bicarbonate. - Metabolic acidosis: provides bicarbonate ions to help normalize blood pH. - Peri‑operative fluid replacement: maintains intravascular volume and electrolyte homeostasis during surgery.
What are the side effects of Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?
Adverse reactions may occur with any intravenous infusion. Monitoring and appropriate infusion rates reduce risk.
Common Side Effects: - Infusion site irritation or phlebitis. - Mild hypernatremia. - Transient hyperkalemia. - Mild hypermagnesemia. - Mild hypocalcemia. - Fluid overload (edema).
Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Severe hypermagnesemia causing respiratory depression. - Anaphylactic or severe allergic reaction. - Rapid shifts in serum calcium resulting in tetany. - Severe fluid overload with pulmonary edema. - Metabolic alkalosis from excess bicarbonate.
What precautions apply to Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?
Use Nefrosol Kálium with clinical monitoring and consider patient‑specific factors. - Renal impairment: adjust infusion rate and monitor electrolyte levels. - Cardiac disease: avoid rapid infusion that may provoke arrhythmias. - Hyperkalemia risk: assess baseline potassium before administration. - Fluid overload: limit volume in patients with heart failure. - Compatibility: verify compatibility with other IV solutions before mixing. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc interact with?
Electrolyte solutions can interact with other medications that affect ion balance.
Major Interactions (Avoid): - Concurrent potassium‑sparing diuretics: risk of dangerous hyperkalemia. - Calcium channel blockers with high calcium content: may cause hypercalcemia. - Sodium‑containing medications: can exacerbate hypernatremia.
Moderate Interactions (Monitor Closely): - Magnesium‑containing laxatives: increase risk of hypermagnesemia. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Anticoagulants: large volume infusion may affect coagulation parameters.